Beranda › Kanker (semua jenis) › Pennsylvania › Pittsburgh
Uji klinis Kanker (semua jenis) di Pittsburgh, PA
41 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
- Allegheny Health Network, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
- UPMC Hillman Cancer Center, Pittsburgh
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
Menerima pesertaStudi observasional
- Allegheny General Hospital, Pittsburgh
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Menerima peserta
- AHN Allegheny General Hospital, Pittsburgh
- Allegheny General Hospital, Pittsburgh
EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
Menerima peserta
- AHN Allegheny General Hospital, Pittsburgh
- AHN Allegheny General Hospital, Pittsburgh
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Menerima pesertaFase 1
- UPMC Cancer Centers, Pittsburgh
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- Allegheny General Hospital (AGH)-Allegheny Singer Research Institute, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Allegheny Health Network, Pittsburgh
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- UPMC Cancer Pavillion, Pittsburgh
Collection of Tissue Samples for Cancer Research
Menerima pesertaStudi observasional
- University of Pittsburgh Medical Center, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Menerima pesertaFase 1/2
- Research Site, Pittsburgh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- UPMC Hillman Cancer Center, Pittsburgh
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Menerima pesertaFase 3
- Allegheny-Singer Research Institution, Pittsburgh
Biennial CEM in Women With a Personal History of Breast Cancer
Menerima pesertaSukarelawan sehat diterima
- Magee-Womens Hospital, Pittsburgh
- Hillman Cancer Center at Shadyside, Pittsburgh
- UPMC Magee-Womens Imaging - Bethel Park, Bethel Park · 8 mi jauhnya
- dan 3 lainnya
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
Menerima peserta
- AHN Allegheny General Hospital, Pittsburgh
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Menerima peserta
- University of Pittsburgh Medical Center (UPMC) Cancer Center, Pittsburgh
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Menerima pesertaFase 2
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Investigating Real-Time Immunotherapy Symptoms Study
Menerima peserta
- UPMC Hillman Cancer Center, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Menerima pesertaFase 2
- 127, Pittsburgh
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
Menerima pesertaStudi observasional
- AHN CI Exercise Oncology and Resiliency Center, Pittsburgh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Children's Hospital of Pittsburgh, Pittsburgh
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
Menerima peserta
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Menerima pesertaFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Menerima pesertaFase 1
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Menerima pesertaFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
Menerima peserta
- Magee-Womens Hospital, Pittsburgh
Testicular Tissue Cryopreservation for Fertility Preservation
Menerima peserta
- Magee-Womens Hospital, Pittsburgh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Menerima pesertaFase 1
- UPMC Hillman Cancer Center, Pittsburgh
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Menerima pesertaFase 1/2
- UPMC Hilman Cancer Center, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Menerima pesertaStudi observasional
- Allegheny Health Network, Pittsburgh
Ovarian Tissue Cryopreservation for Fertility Preservation
Menerima pesertaStudi observasional
- Magee-Womens Hospital, Pittsburgh
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
Menerima pesertaFase 2
- Allegheny Health Network West Penn Hospital, Pittsburgh
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Menerima peserta
- Allegheny General Hospital, Pittsburgh
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Menerima peserta
- Allegheny General Hospital, Pittsburgh
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Menerima peserta
- AHN West Penn Hospital, Pittsburgh
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
Menerima pesertaStudi observasional
- University of Pittsburgh Medical Center, Pittsburgh
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
Studi lain di Pittsburgh
- Kanker Paru Non-Sel Kecil48 studi
- Kanker Payudara39 studi
- Kanker Kolorektal32 studi
- Kanker Metastatik31 studi
- Melanoma31 studi
- Kanker Ovarium30 studi
- Kanker Endometrium23 studi
- Kanker Prostat23 studi
- Kanker Paru23 studi
- Karsinoma Sel Skuamosa Kepala dan Leher22 studi
- Stroke22 studi
- Depresi22 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.